Sugi Predict

Sugi Predict / Compounds / SCHEMBL7595550

SCHEMBL7595550

SCHEMBL7595550

N#CC(C#N)c1cccc2ccccc12

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.54
▸ CYP1A2 P05177 3/20 0.54
▸ CYP2C9 P11712 1/20 0.54
▸ CYP2C19 P33261 1/20 0.54
▸ CA1 P00915 1/20 0.42
▸ CA2 P00918 1/20 0.42
▸ CYP2A6 P11509 3/20 0.40
▸ TSHR P16473 2/20 0.40
▸ HSD17B10 Q99714 2/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40
▸ ADRA2A P08913 4/20 0.39
▸ ADRA2B P18089 4/20 0.39
▸ ADRA2C P18825 4/20 0.39
▸ ADRA1A P35348 4/20 0.39
▸ ADRA1D P25100 3/20 0.39
▸ ADRA1B P35368 3/20 0.39
▸ SLC6A4 P31645 1/20 0.39
▸ ALOX5 P09917 1/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ HPGD P15428 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6412671 0.79 ALDH1A1 (0.50) ALDH1A1CYP1A2CYP2C9CYP2C19CA1
SCHEMBL12238419 0.79 ALDH1A1 (0.50) ALDH1A1CYP1A2CYP2C9CYP2C19CA1
SCHEMBL1527193 0.79 ALDH1A1 (0.50) ALDH1A1CYP1A2CYP2C9CYP2C19CA1
SCHEMBL5692111 0.79 ALDH1A1 (0.55) ALDH1A1CYP1A2CYP2C9CYP2C19CA1
SCHEMBL14201713 0.79 ALDH1A1 (0.50) ALDH1A1CYP1A2CYP2C9CYP2C19CA1
SCHEMBL10928104 0.79 ALDH1A1 (0.61) ALDH1A1CYP1A2CYP2C9CYP2C19CA1
SCHEMBL5692140 0.79 ALDH1A1 (0.50) ALDH1A1CYP1A2CYP2C9CYP2C19CA1
SCHEMBL4822950 0.79 ALDH1A1 (0.50) ALDH1A1CYP1A2CYP2C9CYP2C19CA1
SCHEMBL12238420 0.79 ALDH1A1 (0.50) ALDH1A1CYP1A2CYP2C9CYP2C19CA1
SCHEMBL30820045 0.79 ALDH1A1 (0.50) ALDH1A1CYP1A2CYP2C9CYP2C19CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114512719-B Eutectic solvent-based electrolyte and application thereof 中国科学院青岛生物能源与过程研究所 2024-12-03 — — CN claimed
CN-114512719-A Eutectic solvent-based electrolyte and application thereof 中国科学院青岛生物能源与过程研究所 2022-05-17 — — CN claimed
JP-4173290-A — — None — — JP disclosed
CN-114512719-B Eutectic solvent-based electrolyte and application thereof 中国科学院青岛生物能源与过程研究所 2024-12-03 — — CN disclosed
CN-114512719-A Eutectic solvent-based electrolyte and application thereof 中国科学院青岛生物能源与过程研究所 2022-05-17 — — CN disclosed
EP-0943661-B1 Chromophoric compounds and their preparation process SIEMENS AG (DE) 2002-10-23 — — EP disclosed
US-6353059-B2 CROSSLINKING; STABLE MOLECULAR ORIENTATION SIEMENS AKTIENGESELLSCHAFT (DE) 2002-03-05 — — US disclosed
US-20010053818-A1 Polyadducts produced from nonlinear-optically active copolymers and polymerizable nonlinear-optically active monomers SIEMENS AKTIENGESELLSCHAFT 2001-12-20 — — US disclosed
US-6284889-B1 E.G, 9-(N-(N-HEPTYL)-N-(2-HYDROXYETHYL)AMINO)BENZO(D)ISOTHIAZOLO(3, 3A, 4-AB)PHEN-7,12-OXAZINE 4-DIOXIDE. SIEMENS AKTIENGESELLSCHAFT (DE) 2001-09-04 — — US disclosed
US-6228977-B1 HEAT RESISTANT, MOLECULAR ORIENTATION-STABLE MATERIAL PREPARED FROM NONLINEAR OPTICALLY ACTIVE CHROMOGEN COVALENTLY BOUND TO A CROSSLINKABLE OLIGO- OR POLYCYANURATE AND CURED; ELECTRO-OPTICAL DEVICES SIEMENS AKTIENGESELLSCHAFT (DE) 2001-05-08 — — US disclosed
US-6174961-B1 OPTICAL POLYMERS SIEMENS AKTIENGESELLSCHAFT (DE) 2001-01-16 — — US disclosed
EP-0943661-A2 Chromophoric compounds and their preparation process SIEMENS AKTIENGESELLSCHAFT (DE) 1999-09-22 — — EP disclosed
EP-0941990-A2 Process for the preparation of azamethines and azamethines obtained thereby SIEMENS AKTIENGESELLSCHAFT (DE) 1999-09-15 — — EP disclosed
EP-0767927-B1 USE OF METHINE AND AZOMETHINE DYES BASED ON NAPHTHOQUINONES IN NON-LINEAR OPTICS BASF AG (DE) 1998-09-02 — — EP disclosed
US-5756753-A Methine and azamethine dyes based on naphthoquinones in nonlinear optics BASF AKTIENGESELLSCHAFT (DE) 1998-05-26 — — US disclosed
EP-0767927-A1 USE OF METHINE AND AZOMETHINE DYES BASED ON NAPHTHOQUINONES IN NON-LINEAR OPTICS BASF AKTIENGESELLSCHAFT (DE) 1997-04-16 — — EP disclosed
WO-1996000409-A1 USE OF METHINE AND AZOMETHINE DYES BASED ON NAPHTHOQUINONES IN NON-LINEAR OPTICS BASF AKTIENGESELLSCHAFT (DE) 1996-01-04 — — WO disclosed
US-5192737-A Quinone imine dye FUJI PHOTO FILM CO., LTD. (JP) 1993-03-09 — — US disclosed
JP-H04173290-A THERMAL TRANSFER DYE DONATING MATERIAL FUJI PHOTO FILM CO LTD 1992-06-19 — — JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010053818-A1 Polyadducts produced from nonlinear-optically active copolymers and polymerizable nonlinear-optically active monomers PARG, PARN, ACMSD ALDH1A1 1865/4885CYP1A2 3091/4885CYP2C9 3598/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.